AVPR1B and major depressive disorder: Interestingly, a selective V1b antagonist produces anxiolytic- and antidepressant-like effects in rodents [16] and in humans AVPR1B variants have been associated with recurrent major depression [17], early-onset mood disorders [18] and panic disorder [19].